Publications by authors named "Rosa Guerrero-Tejada"
Cancer Med
September 2016
Article Synopsis
- - The review analyzed 76 phase III trials on advanced NSCLC from 2000 to 2012, noting a significant increase in sample sizes, particularly in trials involving targeted agents and multiple drugs.
- - Quality of life was evaluated in over half of the trials, with some showing improvement, while platinum-based regimens remained the most common treatment examined.
- - Although there was a modest increase in median overall survival (MOS) over the years, significant improvements were observed in only a small percentage of trials, highlighting the need for careful evaluation of trial quality and outcomes before adopting new treatment strategies.
